The ovulation tracking app shared users’ 'precise geolocation information' and health data with third parties, according to the FTC. (via The ReidOut Blog)
The Federal Trade Commission charged that the developer of the fertility app Premom deceived users by sharing their sensitive personal information with third parties, including two China-based firms, disclosed users’ sensitive health data to AppsFlyer and Google, and failed to notify consumers of these unauthorized disclosures in violation of the Health Breach Notification Rule .
Premom “encourages users to provide information about their menstrual cycles, fertility, and pregnancy as well as to import their data from other apps such as Apple Health," the FTC said. The app shared users’"precise geolocation information" as well as their social media and mobile device data with third parties, including the two China-based companies, according to the FTC.
As part of the settlement agreement, the app’s owner, Easy Healthcare, wasn't required to admit wrongdoing.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Settlement reached after fertility app Premom shared user health data with third parties, FTC saysA free fertility app used to track ovulation shared users' health information with other companies, including Google and China-based marketing and analytics firms, the Federal Trade Commission said Wednesday in announcing a $200,000 settlement.
Consulte Mais informação »
FTC accuses fertility tracking app with sharing data with China, GoogleA complaint by the Federal Trade Commission accuses popular fertility tracking app Premom of illegally sharing private data.
Consulte Mais informação »
Ovulation tracker app Premom charged with sharing users' personal informationU.S. regulators said late Tuesday that Easy Healthcare Corp.'s ovulation tracker app Premom shared users "sensitive" personal information with...
Consulte Mais informação »
Infertility is common in the US, but insurance coverage remains limitedCoverage of fertility treatments remains hard to find in many corners of health insurance even as it grows briskly with big employers that see it as a must-have benefit to keep workers. More than half of the largest employers in the U.S. now cover fertility care, which includes in vitro fertilization. Researchers say a divide is growing between people who receive help paying for care and those who are left out. There are also questions about how much fertility coverage should be emphasized or mandated compared to helping people find other ways to build families, such as adoption.
Consulte Mais informação »
US FTC sues to block Amgen's $27.8 bln deal for Horizon TherapeuticsThe U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal.
Consulte Mais informação »
How Kofinas Fertility Group is getting to the root of endometriosisFor too many women, endometriosis is overlooked, and the repercussions can be physically taxing. Pain is a symptom that goes hand in hand with endometriosis – when tissue that lines the uterus grow…
Consulte Mais informação »